Piedra Sol treats program information as material to examine, not promises to repeat. We use publicly available program materials alongside literature, registries, and official sources where they can help establish context. The ClinicalTrials.gov study registry, for example, makes it possible to distinguish a registered study record from a general claim about research.
We aim to describe what is known, note what is not established, and avoid turning incomplete information into advice. That approach matters when reviewing issues such as long-term side-effect questions, where uncertainty should remain visible rather than be smoothed over.
- 01
Safety contextRisk-relevant details deserve direct, careful language.
- 02
Price clarityAdvertised figures are more useful when their inclusions are named.
- 03
Plain languageComplex material should remain understandable without being simplified past recognition.
- 04
IndependenceThe resource does not represent a clinic or treatment provider.
- 05
Informed decisionsInformation can support questions; it cannot substitute for professional judgment.